I for one don't mind the false claims as would like to top up...

I for one don't mind the false claims as would like to top up more in the next 2 months, so fingers crossed it gets hit back down below $2. Pretty sure rac will be at one of those pharma investor conferences with a stand ECT in a year or 2 where every large pharma has reps scouting out drugs to buy. Dare say they will like the fact how many trials have been completed, efficacy and fto blue sky opportunities. Surely would be a low risk buy for them compared to other options. Who knows when will a pharma offer something for rac but may create FOMO for big pharma like a pack of big gt's chasing a lure. Remember people our goal is to stay under the radar for now.